Conditions: Coronary Artery Disease
Intervention Type: Device
Intervention Name: Bx VELOCITY Stent containing 45% and 70% of Sirolimus dose
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Device" intervention "Bx VELOCITY Stent containing 45% and 70% of Sirolimus dose" on "Coronary Artery Disease".
-
An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)
NCTID: NCT00233766
